A recent study from CSIR-CCMB reveals how viral infections may trigger amyloid formation leading to Parkinson's disease.

A new study by CSIR-CCMB researchers has elucidated the molecular mechanisms by which viral infections, particularly RNA viruses like Influenza and COVID-19, can accelerate the formation of amyloid ...

Hyderabad’s CCMB has identified how viral RNA structures may accelerate α-synuclein amyloid formation linked to Parkinson’s ...

New information is emerging about Dennis Haskins‘ health following his death at 75. Kimberly Snow, a friend and caretaker of the Saved by the Bell alum, told The New York Times following news of his ...

Rutgers engineers have developed a smart shoe that automatically analyzes how a person walks, a technology that someday could help monitor people with Parkinson's disease, spinal cord injuries, ...

The actor was diagnosed eight years ago, according to his caretaker.

A new trial led by Cardiff University is exploring whether samba drumming could help improve mobility and wellbeing for people with Parkinson’s disease.

Parkinson’s disease is a brain disorder that gradually affects movement and many other body functions. It develops as nerve ...

Juvmo (tavapadon) offers a novel, selective D1/D5 dopamine receptor partial agonist mechanism for early monotherapy and adjunctive treatment in Parkinson disease.

AbbVie ( ABBV) announced that the U.S. FDA has approved JUVMO (tavapadon) tablets for the treatment of adults with Parkinson's disease, providing a new oral treatment option for a progressive ...

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved JUVMO™ (tavapadon) tablets as the first ...

Bengaluru: The US Food and Drug Administration has approved AbbVie's drug for Parkinson's disease in adults, the health ...